# Genesys Capital: portfolio, investments and team > Genesys Capital is a vc firm based in Canada. 19 investments on record, latest Jun 2021. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/genesys-capital (Millionrounds; every figure on the page links to its filing or article) Canada · [Investor](https://millionrounds.com/investors) # Genesys Capital Last cheque observed Jun 2021. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet New fund $125M, Aug 2016 VC firm Pre-seed Seed Series A Biotechnology Pharmaceuticals Medical Technology Follow Genesys Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fgenesys-capital) Cheques on record **0%** of best year **0** **cheques in 12 months**, 19 on record Since the last cheque **1963** days **00** hrs **00** min **00** sec Median round **$11M** Rounds led **1 of 19** Sole investor **1 rounds** Exits **2 from the portfolio** Mostly in **Canada, 53%** Pitch Genesys Capital ## Genesys Capital highlights - 01 19 rounds on record - 02 Mostly Series A and Series B: 72% of its rounds - 03 Sole investor in 1 rounds, median $1.0M - 04 2 exits from the portfolio ## What they do > Genesys Capital is one of Canada's leading venture capital firms, investing in early-stage healthcare and biotechnology companies From their own website - **Type:** VC firm - **Cheque size:** Not stated - **Stages:** Pre-seed Seed Series A - **Sectors:** Biotechnology Pharmaceuticals Medical Technology - **Based in:** Toronto, Canada - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **19 appearances** - **2021** 1 round - **Jun** **[Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics)** Series A · US · Hatteras Venture Partners **$17M** With 8 others - **2019** 1 round - **Dec** **[EBT Medical](https://millionrounds.com/company/ebt-medical)** Series A · CA · FinSMEs **$10M** With 2 others - **2018** 1 round - **Jul** **[Inversago](https://millionrounds.com/company/inversago)** Series A · CA · FinSMEs **$7.0M** With 4 others - **2017** 1 round - **Feb** **[Fusion Pharmaceuticals](https://millionrounds.com/company/fusion-pharmaceuticals)** Series A · CA · FinSMEs **$25M** With 3 others - **2014** 1 round - **Oct** **[Invitae](https://millionrounds.com/company/invitae)** Series F · US **$120M** With 13 others - **2013** 1 round - **Dec** **[Invitae](https://millionrounds.com/company/invitae)** Series E · US · finsmes.com **$40M** With 4 others - **2012** 2 rounds - **Dec** **[Naurex](https://millionrounds.com/company/naurex)** Series B · US · fiercebiotech.com **$38M** With 6 others - **Apr** **[Tioga Pharmaceuticals](https://millionrounds.com/company/tioga-pharmaceuticals)** Series B · US · tiogapharma.com **$10M** With 1 other - **2011** 3 rounds - **Oct** **[Functional Neuromodulation](https://millionrounds.com/company/functional-neuromodulation)** Series A · CA · biospace.com **$10M** With 1 other - **Jul** **[gIcare Pharma](https://millionrounds.com/company/gicare-pharma)** Series A · CA · finsmes.com **$7.4M** With 1 other - **May** **[Naurex](https://millionrounds.com/company/naurex)** Series A · US · fiercebiotech.com **$18M** With 5 others - **2010** 1 round - **Feb** **[Tioga Pharmaceuticals](https://millionrounds.com/company/tioga-pharmaceuticals)** Series A · US · tiogapharma.com **$18M** With 3 others - **2009** 1 round - **Jul** **[Allostera Pharma](https://millionrounds.com/company/allostera-pharma)** Series C · CA · onbiovc.com **$15M** With 3 others - **2007** 2 rounds - **Aug** **[NeurAxon](https://millionrounds.com/company/neuraxon)** Series B · CA **$32M** With 6 others - **Mar** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Series A · US **$18M** With 3 others - **2006** 2 rounds - **Aug** **[Millenium Biologix](https://millionrounds.com/company/millenium-biologix)** Venture · CA **$1.2M** With 1 other - **Feb** **[StemPath](https://millionrounds.com/company/stempath)** Venture · CA · thefreelibrary.com **$1.0M** Sole investor - **2004** 1 round - **Oct** **[Zelos Therapeutics](https://millionrounds.com/company/zelos-therapeutics)** Series A · US **$5.5M** With 3 others - **Undated** 1 round - **-** **[Giiant Pharma Inc.](https://millionrounds.com/company/giiant-pharma-inc)** Seed · CA · Firms' own news pages **$11M** *Led* An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **9** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **2 in all** **[Naurex](https://millionrounds.com/company/naurex)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$560M** Jul 2015 **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Bought by [Debiopharm Group](https://millionrounds.com/fund/debiopharm-innovat) **Undisclosed** Feb 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$125M** raised in Aug 2016 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Pre-seed Seed Series A Median round joined **$11M** the round, not its cheque Alone, median **$1.0M** Led 1 of 19 rounds **5%** - **Sole investor:** 1 rounds - **Last cheque:** Jun 2021 - **Exits:** 2 from the portfolio Rounds by stage said on their site - Series A said *10* - Series B *3* - Venture *2* - Series F *1* - Series C *1* - Seed said *1* - Pre-seed said *-* Cheques by year Led Joined 2004 2021 Often in the room with - [BDC Capital](https://millionrounds.com/fund/bdc-venture-capital) 3 - [Adams Street Partners](https://millionrounds.com/fund/adams-street-partners) 2 - [Anges Quebec](https://millionrounds.com/fund/anges-quebec) 2 - [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 2 - [Druid BioVentures](https://millionrounds.com/fund/druid-bioventures) 2 - [Forward Ventures](https://millionrounds.com/fund/forward-ventures) 2 **Pitching Genesys Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Genesys Capital. A count of rooms they were both in, not a relationship either has claimed. [**BDC Capital** VC firm **3** rounds together](https://millionrounds.com/fund/bdc-venture-capital)[**Adams Street Partners** VC firm **2** rounds together](https://millionrounds.com/fund/adams-street-partners)[**Anges Quebec** Angel network **2** rounds together](https://millionrounds.com/fund/anges-quebec)[**Casdin Capital** VC firm **2** rounds together](https://millionrounds.com/fund/casdin-capital)[**Druid BioVentures** Investment firm **2** rounds together](https://millionrounds.com/fund/druid-bioventures)[**Forward Ventures** Accelerator **2** rounds together](https://millionrounds.com/fund/forward-ventures)[**Genomic Health** Growth equity **2** rounds together](https://millionrounds.com/fund/genomic-health)[**Latterell Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/latterell-venture-partners)[**OrbiMed** Private equity **2** rounds together](https://millionrounds.com/fund/orbimed)[**PathoCapital** Growth equity **2** rounds together](https://millionrounds.com/fund/pathocapital)[**Randy Scott** Angel **2** rounds together](https://millionrounds.com/fund/randy-scott)[**Redmile Group** VC firm **2** rounds together](https://millionrounds.com/fund/redmile-group) ## Recently backed The latest companies Genesys Capital put money into. [**Veralox Therapeutics** $17M · Jun 2021](https://millionrounds.com/company/veralox-therapeutics)[**EBT Medical** $10M · Dec 2019](https://millionrounds.com/company/ebt-medical)[**Fusion Pharmaceuticals** $25M · Feb 2017](https://millionrounds.com/company/fusion-pharmaceuticals) ## Quick answers about Genesys Capital ### What does Genesys Capital invest in? Genesys Capital invests most often at Series A and Series B (72% of the rounds on record), in sectors such as Biotechnology, Pharmaceuticals and Medical Technology. ### How active is Genesys Capital? 19 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Jun 2021. ### What has Genesys Capital invested in recently? Its most recent investments on record: Veralox Therapeutics (Series A, Jun 2021), EBT Medical (Series A, Dec 2019) and Inversago (Series A, Jul 2018). ### How big are Genesys Capital's cheques? The median round it joins is $11M. ### Does Genesys Capital lead rounds? Sometimes: it led 1 of its 19 investments on record (5%). ### Where does Genesys Capital invest? Most of the companies it backs are in Canada (53%) and the United States (47%). ### Is Genesys Capital investing now? No investments in the last 12 months; the latest was in Jun 2021. ### Who does Genesys Capital invest alongside? Most often BDC Capital (3 rounds together), Adams Street Partners (2 rounds together) and Anges Quebec (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=genesys-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=genesys-capital)